Cisatracurium increases autophagic structures in HeLa cells
Cell-based study · HeLa cells stably transfected with GFP-LC3 (marks autophagosome-like structures) and MitoDsred (marks mitochondria) [1]
HeLa cells stably transfected with markers for autophagosome-like structures and mitochondria were incubated with cisatracurium. The number of autophagic structures increased in a concentration-dependent manner.
| Endpoint | Reported result | Reference |
|---|---|---|
| LC3 green fluorescent puncta in each cell were counted | Reported result With increase in drug concentration, the number of LC3-positive autophagic structures increased in a concentration-dependent manner. | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 2.5 µM, 5 µM, 10 µM, 25 µM, 50 µM, or 100 µM
- Exposure duration
- for 12 h
- Method
- incubated with cisatracurium
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Cisatracurium besylate; Compound label in the paper: Cisatracurium
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
2. Results > 2.1. Cisatracurium Besylate Promotes Mitochondrial Breakage, Mitochondrial Protein Degradation and Colocalization of Mitochondria and Autophagosomes (S6, S7, S9); Figure 1 legend (S130)
LC3 green fluorescent puncta in each cell were counted: LC3 green fluorescent puncta in each cell were counted; comparator: 0 µM — 2. Results > 2.1. Cisatracurium Besylate Promotes Mitochondrial Breakage, Mitochondrial Protein Degradation and Colocalization of Mitochondria and Autophagosomes (S7, S9)